home.aspx
 
EVENTS

The Digital Pharma Advances
THE DIGITAL PHARMA ADVANCES
January 29-29, 2020
Powerfully Target & Engage HCPs & Patients & Deliver Real-World Results With Integrated, Innovative Digital Strategies.Customer-Centric, Value-Adding, Multi-Channel Digital Pharma Marketing Strategies.

4th Annual Microbiome Movement, Drug Development, Europe
4TH ANNUAL MICROBIOME MOVEMENT, DRUG DEVELOPMENT, EUROPE
February 04-05, 2020
As the first microbiome-based therapeutic steps closer to market approval, the scientific community continue to demonstrate the functional role of the human microbiome as a novel source of therapeutic, biomarker and diagnostic development. Despite this progress, the vast potential to develop effecti...

Busamed

SHARESHARESHARE
Busamed is a proudly South African private hospital group offering friendly, cost-effective and innovative healthcare service in a safe and caring environment. Technology and principles of evidence-based practices are applied to provide appropriate medical and nursing care to achieve the best clinical outcomes in partnership with key stake holders.
SHARESHARESHARE

RELATED NEWS


Researchers at Massachusetts General Hospital have found that regular aspirin use can reduce the risk of developing liver cancer. The findings — which appear in JAMA Oncology — support the results of prior studies on the same topic. Data from this report show that taking aspirin on a regular basis can lower the risk of developing liver cancer, or hepatocellular carcinoma (HCC). The scientists defined "a regular basis" as taking two or more 325-milligram tablets per week for...

READ MORE

The FDA has approved a new type of insulin pump that can be used with different components from other diabetes therapy systems. Tandem Diabetes Care’s t:Slim X2 pump—which the agency described as the first in a new category of interoperable hardware, called alternate controller-enabled infusion pumps, or ACE pumps—allows patients to tailor their diabetes management by linking their preferred devices, including compatible automated dosing systems, continuous glucose monitors and...

READ MORE

Medicines Discovery Catapult and ANTRUK Enterprises, a wholly owned subsidiary of the charity Antibiotic Research UK, are working together on the inaugural project at the former’s new facility at the University....

READ MORE

Construction, factory, and farm workers, among others, tend to put a lot of strain on their backs. It’s no surprise that back problems are common in such professions. Paying attention to one’s posture and being careful to avoid putting too much demand on the bones and muscles of the back can certainly help, but not everyone complies while others are injured anyways. There are passive exoskeletons that can help, but they essentially shift the load from one part of the body to another,...

READ MORE

A new structure in human cells has been discovered by researchers at Karolinska Institutet in collaboration with colleagues in the UK. The structure is a new type of protein complex that the cell uses to attach to its surroundings and proves to play a key part in cell division. The study is published in the journal Nature Cell Biology. The cells in a tissue are surrounded by a net-like structure called the extracellular matrix. To attach itself to the matrix the cells have receptor molecules on ...

READ MORE

LEO Pharma has signed a research collaboration deal with PellePharm that commits up to $760 million for late-stage trials and includes an option for LEO to acquire the small rare disease company outright at some point in the future. The deal begins with $70 million in equity financing and R&D support to fund a global phase 3 trial for PellePharm’s patidegib—a hedgehog pathway-inhibiting topical gel for the prevention of Gorlin syndrome, a rare genetic disease that makes people mo...

READ MORE

EVENTS

The Digital Pharma Advances
THE DIGITAL PHARMA ADVANCES
January 29-29, 2020
Powerfully Target & Engage HCPs & Patients & Deliver Real-World Results With Integrated, Innovative Digital Strategies.Customer-Centric, Value-Adding, Multi-Channel Digital Pharma Marketing Strategies.

4th Annual Microbiome Movement, Drug Development, Europe
4TH ANNUAL MICROBIOME MOVEMENT, DRUG DEVELOPMENT, EUROPE
February 04-05, 2020
As the first microbiome-based therapeutic steps closer to market approval, the scientific community continue to demonstrate the functional role of the human microbiome as a novel source of therapeutic, biomarker and diagnostic development. Despite this progress, the vast potential to develop effecti...